Recurrence and Accelerated Progression of Hepatitis C following Liver Transplantation

P. H. Bernard; B. Le Bail; A. Rullier; P. Trimoulet; M. Neau-Cransac; C. Balabaud; P. Bioulac-Sage

doi:10.1055/s-2000-13152

Seminars in Liver Disease, Table of Contents

Semin Liver Dis 2000; 20(4): 533-538
DOI: 10.1055/s-2000-13152

Recurrence and Accelerated Progression of Hepatitis C following Liver Transplantation

P. H. Bernard, B. Le Bail, A. Rullier, P. Trimoulet, M. Neau-Cransac, C. Balabaud, P. Bioulac-Sage

Service d'Anatomie Pathologique , laboratoire de Virologie, et Service de Chirurgie Digestive et de Transplantation Hépatique, Hôpitaux Pellegrin et St André, C.H.U. Bordeaux, France

Abstract

Full Text

References

REFERENCES

1 Ballardini G, Groff P, Giostra F. Hepatocellular codistribution of c100, c33, c22, and NS5 hepatitis C virus antigens detected by using immunopurified polyclonal spontaneous human antibodies. Hepatology . 1995; 21 730-734
2 Feray C, Gigou M, Samuel D, Paradis V. The course of hepatitis C infection after liver transplantation. Hepatology . 1994; 20 1137-1143
3 Wright T L, Donegant E, Hsu H H. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology . 1992; 103 317-322
4 Gane E J, Portmann B C, Naoumov N V. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med . 1996; 334 815-820
5 Feray C, Caccamo L, Alexander G J. European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. Gastroenterology . 1999; 117 619-625
6 Prieto M, Berenguer M, Rayon J M. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes. Hepatology . 1999; 29 250-256
7 Gordon F D, Poterucha J J, Germer J. Relationship between hepatitis C genotype and severity of recurrent hepatitis C after liver transplantation. Transplantation . 1997; 63 1419-1423
8 Schluger L K, Sheiner P A, Thung S N. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology . 1996; 23 971-976
9 Dickson R C, Caldwell S H, Ishitani M B. Clinical and histological pattern of early graft failure due to recurrent hepatitis C in four patients after liver transplantation. Transplantation . 1996; 61 701-706
10 Davies S E, Portmann B C, O'Grady J G. Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis. Hepatology . 1991; 13 150-157
11 Zylberberg H, Carnot F, Mamzer M F. Hepatitis C virus-related fibrosing cholestatic hepatitis after renal transplantation. Transplantation . 1997; 63 158-160
12 Waguri N, Ichida T, Fujimaki R. Fibrosing cholestatic hepatitis after living related-donor renal transplantation. J Gastroenterol Hepatol . 1998; 13 1133-1137
13 Toth C M, Pascual M, Chung R T. C virus-associated fibrosing cholestatic hepatitis after renal transplantation: response to interferon-alpha therapy. Transplantation . 1998; 66 1254-1258
14 Vargas H E, Laskus T, Wang L F. The influence of hepatitis C virus genotypes on the outcome of liver transplantation. Liver Transpl Surg . 1998; 4 22-27
15 Zhou S, Terralt N A, Ferrell L. Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia. Hepatology . 1996; 24 1041-1046
16 Gane E J, Naoumov N V, Quian K P. A longitudinal analysis of hepatitis virus replication following liver transplantation. Gastroenterology . 1996; 110 167-177
17 Feray C, Gigou M, Samuel D. Influence of the genotypes of hepatitis C virus on the severity of the recurrent liver disease after liver transplantation. Gastroenterology . 1995; 108 1088-1096
18 Manez R, Mateo R, Tabasco J. The influence of HLA donor-recipient compatibility on the recurrence of HBV and HCV hepatitis after liver transplantation. Transplantation . 1995; 59 640-642
19 Gretch D, Wile M, Gaur L. Donor recipient match at the HLA-DQB locus is associated with recrudescence of chronic hepatitis following liver transplantation for end stage hepatitis C. Hepatology . 1993; 18(Suppl) 18A
20 Boker K HW, Dalley G, Bahr M J. Long-term outcome of hepatitis C virus infection after liver transplantation. Hepatology . 1997; 25 203-210
21 Gayowski T, Singh N, Marino I R. Hepatitis C virus genotypes in liver transplant recipients: impact on post-transplant recurrence, infections, response to interferon-alpha therapy and outcome. Transplantation . 1997; 64 422-426
22 Berenguer M, Prieto M, Cordoba J. Early development of chronic active hepatitis in recurrent hepatitis C virus infection after liver transplantation: association with treatment of rejection. J Hepatol . 1998; 28 756-763
23 Shuhart M C, Bronner M P, Gretch D R. Histological and clinical outcome after liver transplantation for hepatitis C. Hepatology . 1997; 26 1646-1652
24 Charlton M, Seaberg E, Wiesner R. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology . 1998; 28 823-830
25 Doughty A L, Spencer J D, Cossart Y E, McCaughan G W. Cholestatic hepatitis after liver transplantation is associated with persistently high serum hepatitis C virus RNA levels. Liver Transpl Surg . 1998; 4 15-21
26 Rosen H R, Gretch D R, Oehlke M. Timing and severity of initial hepatitis C recurrence as predictors of long-term liver allograft injury. Transplantation . 1998; 65 1178-1182
27 Sheiner P, Schwartz M E, Mor E. Severe or multiple rejection episodes are associated with early recurrence of heptitis C after orthotopic liver transplantation. Hepatology . 1995; 21 30-34
28 Herrero J I, de la Pena A, Quiroga J. Risk factors for recurrence of hepatitis C after liver transplantation. Liver Transpl Surg . 1998; 4 265-270
29 Freeman R B, Tran S, Lee Y M, Rohrer R J, Kaplan M M. Serum hepatitis C RNA titers after liver transplantation are not correlated with immunosuppression or hepatitis. Transplantation . 1996; 61 542-546
30 Farges O, Feray C, Samual D. The level of immunosuppression does not influence the natural history of recurrent disease in patients transplanted for HCV cirrhosis. J Hepatol . 1995; 23(Suppl 1) 84
31 Zervos X A, Weppler D, Fragulidis G P. Comparison of tacrolimus with neoral as primary immunosuppression in hepatitis C patients after liver transplantation. Transplantation . 1998; 65 1444-1446
32 Bizollon T, Palazzo U, Ducerf C. Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation. Hepatology . 1997; 26 500-504
33 Fischer L, Sterneck M, Valentin-Gamazo C. Treatment of severe recurrent hepatitis C after liver transplantation with ribavirin plus interferon alpha. Transpl Proc . 1999; 31 494-495